A trio of Miller School of Medicine investigators has received a $4.9 million grant from the National Institutes of Health for a collaborative effort to move the search for novel treatments for diabetes to a new level. The grant, one of only four awarded, is a part of the Consortium on Human Islet Biomimetics, a group under the newly formed Human Islet Research Network.
Renal Pathology ServiceMore info
39th REVIEW AND ADVANCES IN PATHOLOGYMore info
Among the Nation’s BestLearn More
Dedicated to Providing Quality Patient CareLearn More
Providing the Highest Quality EducationLearn More
Tan A. Ince, M.D., Ph.D., associate professor of pathology and member of the University of Miami’s Sylvester Comprehensive Cancer Center, has received a $250,000 grant from the Breast Cancer Research Foundation (BCRF) to research personalized treatment of breast tumors with multi-hormone combinations.
Researchers have presented data that supports the cancer fighting potential of growth hormone-releasing hormone technology developed by two Miller School of Medicine scientists. The work was featured in a September 5 presentation at the American Society of Clinical Oncology’s (ASCO) Breast Cancer Symposium 2014.